tradingkey.logo

Avanos Medical Inc

AVNS
View Detailed Chart

12.280USD

+0.420+3.54%
Close 09/18, 16:00ETQuotes delayed by 15 min
568.74MMarket Cap
LossP/E TTM

Avanos Medical Inc

12.280

+0.420+3.54%
Intraday
1m
30m
1h
D
W
M
D

Today

+3.54%

5 Days

-1.05%

1 Month

+9.16%

6 Months

-16.06%

Year to Date

-22.86%

1 Year

-49.28%

View Detailed Chart

TradingKey Stock Score

Currency: USD Updated: 2025-09-18

Key Insights

The company's fundamentals are relatively very healthy. Its valuation is considered fairly valued,and institutional recognition is very high. Over the past 30 days, multiple analysts have rated the company as a Hold. Despite an average stock market performance, the company shows strong fundamentals and technicals. The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

Score

Industry at a Glance

Industry Ranking
71 / 207
Overall Ranking
187 / 4721
Industry
Healthcare Equipment & Supplies

Support & Resistance

No Data

Score Analysis

Current score
Previous score

Analyst Rating

Based on 1 analysts
Hold
Current Rating
14.000
Target Price
+13.73%
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Company Highlights

StrengthsRisks
Avanos Medical, Inc. is a medical device company, which is focused on delivering solutions. The Company offers healthcare needs, such as providing nutrition to patients from hospital to home and reducing the use of opioids while helping patients move from surgery to recovery. The Company conducts its business in one segment that provides its medical device products to healthcare providers and patients globally with manufacturing facilities in the United States and Mexico. Its digestive health products include MIC-KEY enteral feeding tubes, Corpak patient feeding solutions and NeoMed neonatal and pediatric feeding solutions. The Company’s acute pain products include ON-Q and ambIT surgical pain pumps and Game Ready cold and compression therapy systems. The Company's interventional pain solutions include COOLIEF pain therapy and OrthogenRxs knee osteoarthritis pain relief injection products.
Fairly Valued
The company’s latest PE is -1.22, at a medium 3-year percentile range.
Institutional Selling
The latest institutional holdings are 45.34M shares, decreasing 6.94% quarter-over-quarter.
Held by The Vanguard
Star Investor The Vanguard holds 4.40M shares of this stock.
Higher Market Activity
The company has more investor interest, with a 20-day turnover ratio of 1.26.

News

More news coming soon, stay tuned...

Financial Indicators

EPS

No Data

Total revenue

No Data

Company

Avanos Medical, Inc. is a medical device company, which is focused on delivering solutions. The Company offers healthcare needs, such as providing nutrition to patients from hospital to home and reducing the use of opioids while helping patients move from surgery to recovery. The Company conducts its business in one segment that provides its medical device products to healthcare providers and patients globally with manufacturing facilities in the United States and Mexico. Its digestive health products include MIC-KEY enteral feeding tubes, Corpak patient feeding solutions and NeoMed neonatal and pediatric feeding solutions. The Company’s acute pain products include ON-Q and ambIT surgical pain pumps and Game Ready cold and compression therapy systems. The Company's interventional pain solutions include COOLIEF pain therapy and OrthogenRxs knee osteoarthritis pain relief injection products.
Ticker SymbolAVNS
CompanyAvanos Medical Inc
CEOMr. David Pacitti
Websitehttps://avanos.com/
KeyAI